Publication

Effectiveness of a Web-Based Provider Communications Platform in Reducing Hospital Readmissions Among Patients Receiving Dialysis: A Pilot Pre-Post Study

Downloadable Content

Persistent URL
Last modified
  • 05/14/2025
Type of Material
Authors
    Laura Plantinga, Emory UniversityAnjali Khakharia, Emory UniversityCourtney Hoge, Emory UniversityAnn Vandenberg, Emory UniversityJanice P. Lea, Emory UniversityTahsin Masud, Emory UniversityCarol Gray, Emory UniversityChristopher O'Donnell, Emory UniversityKyle James, Emory UniversityRich Mutell, Johns Hopkins UniversityBernard G. Jaar, Johns Hopkins University
Language
  • English
Date
  • 2022-08-01
Publisher
  • Elsevier
Publication Version
Copyright Statement
  • © 2022 The Authors
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 4
Issue
  • 8
Grant/Funding Information
  • Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number R18DK118467. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in the study design; collection, analysis, or interpretation of data; or the decision to submit the report for publication.
Supplemental Material (URL)
Abstract
  • Rationale & Objective Suboptimal care coordination between dialysis facilities and hospitals is an important driver of 30-day hospital readmissions among patients receiving dialysis. We examined whether the introduction of web-based communications platform (“DialysisConnect”) was associated with reduced hospital readmissions. Study Design Pilot pre-post study. Setting & Participants A total of 4,994 index admissions at a single hospital (representing 2,419 patients receiving dialysis) during the study period (January 1, 2019-May 31, 2021). Intervention DialysisConnect was available to providers at the hospital and 4 affiliated dialysis facilities (=intervention facilities) during the pilot period (November 1, 2020-May 31, 2021). Outcomes The primary outcome was 30-day readmission; secondary outcomes included 30-day emergency department visits and observation stays. Interrupted time series and linear models with generalized estimating equations were used to assess pilot versus prepilot differences in outcomes; difference-in-difference analyses were performed to compare these differences between intervention versus control facilities. Sensitivity analyses included a third, prepilot/COVID-19 period (March 1, 2020-October 31, 2020). Results There was no statistically significant difference in the monthly trends in the 30-day readmissions pilot versus prepilot periods (−0.60 vs -0.13, P = 0.85) for intervention facility admissions; the difference-in-difference estimate was also not statistically significant (0.54 percentage points, P = 0.83). Similar analyses including the prepilot/COVID-19 period showed that, despite a substantial drop in admissions at the start of the pandemic, there were no statistically significant differences across the 3 periods. The age-, sex-, race-, and comorbid condition-adjusted, absolute pilot versus prepilot difference in readmissions rate was 1.8% (−3.7% to 7.3%); similar results were found for other outcomes. Limitations Potential loss to follow-up and pandemic effects. Conclusions In this pilot, the introduction of DialysisConnect was not associated with reduced hospital readmissions. Tailored care coordination solutions should be further explored in future, multisite studies to improve the communications gap between dialysis facilities and hospitals.
Author Notes
  • Laura Plantinga, PhD, Wesley Wood Health Center, 1841 Clifton Road NE, Room 552, Atlanta, GA 30329. laura.plantinga@emory.edu
Keywords
Research Categories
  • Health Sciences, Health Care Management
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items